Antidepressants in bipolar depression: The clinical debate

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 4, 2012, Pages 298-301

  Ghaemi, S Nassir ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; LITHIUM; OLANZAPINE; PAROXETINE; PLACEBO; QUETIAPINE;

BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; DRUG EFFICACY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FEVER; FOLLOW UP; HUMAN; LONG TERM CARE; META ANALYSIS (TOPIC); MONOTHERAPY; NOTE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE; ARTICLE; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; METHODOLOGY; PSYCHOLOGICAL ASPECT;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84865281898     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412441035     Document Type: Note

References (23)

1. Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. American Journal of Psychiatry. 2003 ; 160: 1252-1262 (Pubitemid 41070941)
2. Amsterdam JD. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. Journal of Clinical Psychopharmacology. 1998 ; 18: 414-417
3. Amsterdam JD, Brunswick DJ. Antidepressant monotherapy for bipolar type II major depression. Bipolar Disorders. 2003 ; 5: 388-395 (Pubitemid 38072241)
4. Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. American Journal of Psychiatry. 2010 ; 167: 792
5. Baldessarini R, Henk H, Sklar A, et al. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatric Services. 2008 ; 59: 1175-1183
6. Coryell W, Solomon D, Turvey C, et al. The long-term course of rapid-cycling bipolar disorder. Archives of General Psychiatry. 2003 ; 60: 914-920 (Pubitemid 37122311)
7. Cossman D. Obedience training. General Surgery News. 2007 ; 33: 11
8. Ghaemi SN A Clinician's Guide to Statistics and Epidemiology in Mental Health: Measuring Truth and Uncertainty. Cambridge: Cambridge University Press ; 2009 :
9. Ghaemi SN, Goodwin FK. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use. Journal of Affective Disorders. 2001 ; 65: 281-287 (Pubitemid 32757159)
10. Ghaemi SN, Hsu DJ, Soldani F, et al. Antidepressants in bipolar disorder: the case for caution. Bipolar Disorders. 2003 ; 5: 421-433 (Pubitemid 38072244)
11. Ghaemi SN, Ostacher MM, El-Mallakh RS, et al. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. Journal of Clinical Psychiatry. 2010 ; 71: 372-380
12. Ghaemi SN, Wingo AP, Filkowski MA, et al. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatrica Scandanavica. 2008 ; 118: 347-356
13. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. American Journal of Psychiatry. 2004 ; 161: 1537-1547 (Pubitemid 39201448)
14. Goodwin FK, Whitham EA, Ghaemi SN. Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?. CNS Drugs. 2011 ; 25: 819-827
15. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. American Journal of Psychiatry. 2006 ; 163: 232-239 (Pubitemid 44480842)
16. Malhi GS, Gershon S. Ion men and their mettle. Australian and New Zealand Journal of Psychiatry. 2009 ; 43: 1091-1095
17. McElroy SL, Weisler RH, Chang W, et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). Journal of Clinical Psychiatry. 2010 ; 71: 163-174
18. Parker G, Tully L, Olley A, et al. SSRIs as mood stabilizers for bipolar II disorder? A proof of concept study. Journal of Affective Disorders. 2006 ; 92: 205-214
19. Post RM, Altshuler LL, Leverich GS, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. British Journal of Psychiatry. 2006 ; 189: 124-131 (Pubitemid 44231270)
20. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine. 2007 ; 356: 1711-1722 (Pubitemid 46658703)
21. Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. Journal of Clinical Psychiatry. 2011 ; 72: 156-167
22. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry. 2003 ; 60: 1079-1088 (Pubitemid 37429647)
23. Wehr TA, Sack DA, Rosenthal NE, et al. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. American Journal of Psychiatry. 1988 ; 145: 179-184 (Pubitemid 18058361)